Biomet reports surging profits during its fiscal 2nd quarter, citing a nearly $70 million decrease in legal costs compared with the same period last year.
Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Zimmer proposes divestitures for EU regulators in Biomet deal; China, South Korea OK Medtronic's $43B Covidien buy; BTG to buy PneumRx for up to $475m; BD prices $6.2B bond issue for CareFusion buy; Danaher's Leica division closes Devicor Medical buy
, Becton Dickinson & Co.
, CareFusion Corp.
, Danaher Corp.
, Devicor Medical Products
, European Commission
, Leica Biosystems
, PneumRx Inc.
Zimmer proposes to mollify European anti-trust regulators on its pending, $13 billion acquisition of rival Biomet by selling off some of its knee and elbow assets in Europe.
Zimmer says it agreed with the European Commission to extend the EuroZone review of its pending, $13.4 billion acquisition of cross-town orthopedics rival Biomet.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m
Here's a look at some of the top legal news stories for medical device companies this week: Smith & Nephew claims another win in patent spat with Arthrex; Biomet inks $6m deal to settle kickback charges; Insurer owes Stryker $8m for Duracon Uni-Knee settlements
Zimmer reveals the management team and business structure it plans to put in place once its $13 billion merger with rival Biomet closes.